Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized olmesartan and diabetes microalbuminuria prevention study (ROADMAP)

Trial Profile

Randomized olmesartan and diabetes microalbuminuria prevention study (ROADMAP)

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary)
  • Indications Cardiovascular disorders; Diabetic nephropathies; Hypertension in diabetes; Proteinuria
  • Focus Registrational; Therapeutic Use
  • Acronyms ROADMAP
  • Most Recent Events

    • 25 Sep 2013 Results of the pre-specified ECG analysis (n=1513) presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 10 Mar 2011 Results published in the New England Journal of Medicine.
    • 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD), 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top